AWA
MYOV

Arkadios Wealth Advisors’s Myovant Sciences Ltd. MYOV Stock Holding History

Arkadios Wealth Advisors’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-300
Closed -$6K – 1904
2021
Q3 		$6K Hold
300
– – ﹤0.01% 1575
2021
Q2 		$6K Hold
300
– – ﹤0.01% 1700
2021
Q1 		$6K Hold
300
– – ﹤0.01% 1337
2020
Q4 		$8K Hold
300
– – ﹤0.01% 1032
2020
Q3 		$4.97K Buy
+300
New +$5.58K ﹤0.01% 847

Other funds holding MYOV

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Arkadios Wealth Advisors's MYOV Position: Q4 2021 in Review

Arkadios Wealth Advisors sold out of Myovant Sciences Ltd. (MYOV) in Q4 2021, closing a stake of 300 shares — an estimated $6K sold.

Arkadios Wealth Advisors first reported a position in MYOV in Q3 2020 and held it in 5 quarters. The position peaked at $8K in Q4 2020. 110 funds tracked by Wall St. Rank hold MYOV as of Q4 2021.

  • Arkadios Wealth Advisors reported no remaining Myovant Sciences Ltd. position as of Q4 2021 after selling out during the quarter.
  • Arkadios Wealth Advisors sold 300 Myovant Sciences Ltd. shares in Q4 2021, an estimated $6K.
  • Arkadios Wealth Advisors first reported a position in Myovant Sciences Ltd. in Q3 2020 and held it in 5 quarters.
  • Arkadios Wealth Advisors's Myovant Sciences Ltd. position peaked at $8K in Q4 2020.
  • 110 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2021.

Based on Arkadios Wealth Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.